Six Degrees was approached to develop from scratch a new brand in the excess & surplus insurance space that would immediately and successfully compete with established Fortune 500 competitors.
Molecular sequencing solutions from Thermo Fisher Scientific are well-known in research labs the world over, but not in clinical labs. The company asked Six Degrees to develop a campaign that would resonate with clinical lab managers.
Well-known in research and large reference labs, Thermo Fisher Scientific was aiming to bring next-gen sequencing (NGS) to the broader clinical lab market with their new Ion Torrent Genexus System. The company came to Six Degrees to develop the launch campaign for this breakthrough product.
Mallinckrodt Pharmaceuticals approached Six Degrees to help them name and create a brand identity for an upcoming trial to test the efficacy of a particular drug in treating pulmonary sarcoidosis.